Prothena Future Growth
Future criteria checks 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Prothena.
Key information
23.2%
Earnings growth rate
24.8%
EPS growth rate
| Biotechs earnings growth | 55.0% |
| Revenue growth rate | 58.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 09 May 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 141 | -173 | -61 | N/A | 6 |
| 12/31/2024 | 60 | -210 | -114 | N/A | 10 |
| 12/31/2023 | 14 | -217 | -41 | N/A | 10 |
| 3/31/2020 | 1 | -80 | -59 | -59 | N/A |
| 12/31/2019 | 1 | -78 | -54 | -53 | N/A |
| 9/30/2019 | 1 | -79 | -62 | -60 | N/A |
| 6/30/2019 | 1 | -84 | -86 | -84 | N/A |
| 3/31/2019 | 1 | -128 | -16 | -14 | N/A |
| 12/31/2018 | 1 | -156 | -30 | -28 | N/A |
| 9/30/2018 | 1 | -181 | -47 | -47 | N/A |
| 6/30/2018 | 1 | -209 | -32 | -31 | N/A |
| 3/31/2018 | 27 | -167 | -126 | -125 | N/A |
| 12/31/2017 | 28 | -153 | -135 | -131 | N/A |
| 9/30/2017 | 27 | -154 | -136 | -125 | N/A |
| 6/30/2017 | 28 | -145 | -156 | -138 | N/A |
| 3/31/2017 | 1 | -168 | -148 | -129 | N/A |
| 12/31/2016 | 1 | -160 | N/A | -116 | N/A |
| 9/30/2016 | 1 | -135 | N/A | -102 | N/A |
| 6/30/2016 | 1 | -115 | N/A | -89 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0PT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0PT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0PT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0PT's revenue (58.8% per year) is forecast to grow faster than the German market (4.5% per year).
High Growth Revenue: 0PT's revenue (58.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0PT's Return on Equity is forecast to be high in 3 years time